These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 9723686

  • 1. The clinical efficacy of H1 antagonists in urticaria and rhinitis.
    Rihoux JP, Donnelly F, Burtin B.
    J Allergy Clin Immunol; 1998 Aug; 102(2):333-4. PubMed ID: 9723686
    [No Abstract] [Full Text] [Related]

  • 2. Clinical pharmacology of the H1-receptor antagonists cetirizine and loratadine in children.
    Simons FE, Johnston L, Simons KJ.
    Pediatr Allergy Immunol; 2000 May; 11(2):116-9. PubMed ID: 10893015
    [Abstract] [Full Text] [Related]

  • 3. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH, Briscoe M, Widlitz MD.
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [Abstract] [Full Text] [Related]

  • 4. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
    MMW Fortschr Med; 2003 May 29; 145(22):51. PubMed ID: 12866281
    [No Abstract] [Full Text] [Related]

  • 5. Same drug, different outcomes in the environmental exposure unit.
    Stone BD.
    J Allergy Clin Immunol; 1999 Apr 29; 103(4):715. PubMed ID: 10200027
    [No Abstract] [Full Text] [Related]

  • 6. Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis.
    Day JH, Briscoe MP, Clark RH, Ellis AK, Gervais P.
    Ann Allergy Asthma Immunol; 1997 Aug 29; 79(2):163-72. PubMed ID: 9291422
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
    Simpson K, Jarvis B.
    Drugs; 2000 Feb 29; 59(2):301-21. PubMed ID: 10730552
    [Abstract] [Full Text] [Related]

  • 9. [Antihistaminics. Side effects also after raising dosage at the placebo level].
    MMW Fortschr Med; 2003 May 29; 145(22):50-1. PubMed ID: 12866280
    [No Abstract] [Full Text] [Related]

  • 10. Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine.
    Persi L, Demoly P, Harris AG, Tisserand B, Michel FB, Bousquet J.
    J Allergy Clin Immunol; 1999 Apr 29; 103(4):591-4. PubMed ID: 10200006
    [Abstract] [Full Text] [Related]

  • 11. The new H1 antihistamines. Treatment of urticaria and other clinical problems.
    Goldsmith P, Dowd PM.
    Dermatol Clin; 1993 Jan 29; 11(1):87-95. PubMed ID: 8094649
    [Abstract] [Full Text] [Related]

  • 12. Levocetirizine (Xyzal) for allergic rhinitis and urticaria.
    Med Lett Drugs Ther; 2007 Dec 03; 49(1275):97-9. PubMed ID: 18046285
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical aspects of anti-inflammatory action of antihistamines].
    Grzelewska-Rzymowska I.
    Pol Merkur Lekarski; 2003 Jun 03; 14(84):634-8. PubMed ID: 14524290
    [Abstract] [Full Text] [Related]

  • 14. [H1 histamine antagonists].
    Duchateau J, Heenen M, Sternon J.
    Rev Med Brux; 2003 Apr 03; 24(2):95-100. PubMed ID: 12806876
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA, Riethuisen JM, Moulaert B, DeVos C.
    Ann Allergy Asthma Immunol; 2002 Feb 03; 88(2):190-7. PubMed ID: 11868924
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
    Howarth PH, Stern MA, Roi L, Reynolds R, Bousquet J.
    J Allergy Clin Immunol; 1999 Nov 03; 104(5):927-33. PubMed ID: 10550734
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.